J2350 — Ocrelizumab 30 Mg/ml Intravenous Solution
$17,838
All-payer median here
$37,807
Cash / self-pay here
9
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.